Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2008, Vol. 13 ›› Issue (12): 1416-1421.

Previous Articles     Next Articles

Transcriptional regulation of CYP3A4 and MDR1 mediated via nuclear receptor PXR by helicid

XIE Hai-tang1,2, WANG Guo1, FAN Lan1, ZHANG Li-sheng3, DAI Xiao-chang3, ZHOU Honghao1   

  1. 1Institute of Clinical Pharmacology, Central South University, Changsha 410078, Hunan, China;
    2Anhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu 241001, Anhui, China;
    3Kunming Baker Norton Pharmaceutical Co., Ltd, Kunming 650100, Yunnan, China
  • Received:2008-12-31 Revised:2009-01-05 Published:2020-10-30

Abstract: AIM: To establish nuclear receptor PXR-expressed CYP3A4 and MDR1 dual luciferase reporter gene platform, and analyze the effect of helicid on hPXR-mediated transcriptional regulation of CYP3A4 and MDR1 genes.METHODS: PXR expression plasmid and reporter gene plasmid of either CYP3A4 or MDR1 were constructed based upon the dual luciferase reporter gene platform, and co-transfected to HepG2 cells.The transfected cells were treated with helicid of various concentrations (0.004, 0.04 and 0.4 μmol/L) for 48 hours while rifampin (10 μmol/L) was included as the positive control.Cells were lysized and luciferase activity was determined using a Dual-luciferase reporter assay kit (Promega, Madison, WI).RESULTS: Helicid, at tested concentrations, did not significantly increase promoter activities of CYP3A4 and MDR1 in HepG2 cells transfected with PXR expression plasmid (P >0.05).CONCLUSION: Nuclear receptor PXR-expressed CYP3A4 and MDR1 dual luciferase reporter gene platforms were successfully established, and helicid does not significantly induce the transcription of CYP3A4 and MDR1.

Key words: helicid, human pregnant X receptor, CYP3A4, MDR1

CLC Number: